By Ernie Mundell and Robin Foster HealthDay Reporters FRIDAY, June 18, 2021 — After spending billions to speed the creation of COVID-19 vaccines, the United States said Thursday that it will now devote $ 3.2 billion to the development of antiviral pills that could stop the new coronavirus before it does its worst damage. Along… Read More »
Novartis and Amgen were the first onto the CGRP scene with migraine drug Aimovig, but tensions ensued shortly into the drug’s launch as both partners filed dueling lawsuits against each other. But now with the migraine market becoming increasingly crowded, Novartis will cede U.S. Aimovig operations over to Amgen. Novartis will hand previously shared joint… Read More »
BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 6 through 11 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a… Read More »
Advertisement Continue reading the main story Supported by Continue reading the main story Remote Work’s Last Hurrah: 6 Spots to Make Your Summer Office As workers prepare to return to the office in coming months, here are six towns and cities to consider squeezing in a working vacation or two. Honolulu, Hawaii, is an idyllic… Read More »